Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

951
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
951
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

975
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
975
Long-term Depression01:03

Long-term Depression

3.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.7K
Long-term Depression01:05

Long-term Depression

33.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuron type-specific translatomes in dorsal hippocampus during early memory consolidation.

Nature communications·2026
Same author

Activity-dependent protein synthesis in neurons requires microglial-metabolic coupling.

Cell metabolism·2026
Same author

Functional border-associated macrophages limit Alzheimer's Disease progression.

bioRxiv : the preprint server for biology·2026
Same author

Microglia coordinate activity-dependent protein synthesis in neurons through metabolic coupling.

bioRxiv : the preprint server for biology·2025
Same author

Prefrontal oxytocin receptor positive cells mediate stress-induced anxiety in tuberous sclerosis complex.

Communications biology·2025
Same author

Neuron type-specific mRNA translation programs provide a gateway for memory consolidation.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

752

How ketamine helps to overcome depression.

Thu N Huynh1, Eric Klann2

  • 1Center for Neural Science, New York University, New York, United States.

Elife
|December 16, 2014
PubMed
Summary

Genetically modified mice reveal how ketamine targets NMDA receptors to alleviate depression symptoms. This research offers new insights into ketamine

Keywords:
cell biologycortexdepressionelectrophysiologyketaminemouseneuroscienceprotein synthesisratsynapse

More Related Videos

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

1.0K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

752
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

1.0K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.8K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Ketamine is an anesthetic with rapidly acting antidepressant effects.
  • The precise neural mechanisms underlying ketamine's antidepressant action are not fully understood.
  • N-methyl-D-aspartate (NMDA) receptors are implicated in depression and ketamine's effects.

Purpose of the Study:

  • To investigate the role of NMDA receptors in mediating ketamine's antidepressant effects.
  • To utilize genetically modified mouse models to elucidate the molecular targets of ketamine.

Main Methods:

  • Employing genetically modified mice with altered NMDA receptor function.
  • Administering ketamine and assessing behavioral and neurochemical changes.
  • Analyzing synaptic plasticity and neuronal signaling pathways.

Main Results:

  • Genetically modified mice exhibited differential responses to ketamine.
  • Ketamine's antidepressant effects were directly linked to its interaction with specific NMDA receptor subunits.
  • Evidence suggests ketamine modulates downstream signaling cascades crucial for mood regulation.

Conclusions:

  • NMDA receptor activity is critical for ketamine's efficacy in reducing depression symptoms.
  • Genetically engineered mouse models provide a powerful tool for dissecting neuropharmacological mechanisms.
  • These findings advance our understanding of ketamine's therapeutic potential and guide future drug development.